Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice

被引:40
作者
Ezzahiri, R
Stassen, FRM
Kurvers, HAJM
van Pul, MML
Kitslaar, PJEHM
Bruggeman, CA
机构
[1] Uinv Hosp Maastricht, Dept Vasc Surg, NL-6202 AZ Maastricht, Netherlands
[2] Uinv Hosp Maastricht, Dept Med Microbiol, NL-6202 AZ Maastricht, Netherlands
关键词
Chlamydia pneumoniae; unstable plaques; matrix metalloproteinases; fibrous cap area;
D O I
10.1053/ejvs.2002.1913
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: to study whether Chlamycdia pneumoniae (Cpn) infection affects atherosclerotic plaque morphology in atherogenic (LDLr/ApoE(-/-)) mice. Methods: in mice sacrificed 20 or 40 weeks after Cpn infection aortic arch sections were analysed for lesion and fibrous cap area and the presence of matrix metalloproteinases (MMP)-2 and -9. Results: all infected mice seroconverted, demonstrated Cpn DNA in their aortas on PCR and developed atherosclerotic plaques. Infection was not associated with changes in lesion area or type, but was associated with reduced the fibrous cap area and increased MMP-2 and -9 immunoreactivity. Conclusion: these findings suggest that Cpn infection may predispose to plaque instability.
引用
收藏
页码:88 / 95
页数:8
相关论文
共 30 条
[1]   Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice [J].
Aalto-Setälä, K ;
Laitinen, K ;
Erkkilä, L ;
Leinonen, M ;
Jauhiainen, M ;
Ehnholm, C ;
Tamminen, M ;
Puolakkainen, M ;
Penttilä, I ;
Saikku, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :578-584
[2]   Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines [J].
Blessing, E ;
Kuo, CC ;
Lin, TM ;
Campbell, LA ;
Bea, F ;
Chesebro, B ;
Rosenfeld, ME .
CIRCULATION, 2002, 105 (16) :1976-1982
[3]   Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women [J].
Bloemenkamp, DGM ;
Mali, WPTM ;
Tanis, BC ;
Rosendaal, FR ;
van den Bosch, MAAJ ;
Kemmeren, JM ;
Algra, A ;
Ossewaarde, JM ;
Visseren, FLJ ;
van Loon, AM ;
van der Graaf, Y .
ATHEROSCLEROSIS, 2002, 163 (01) :149-156
[4]  
Caligiuri G, 2001, CIRCULATION, V103, P2834
[5]   Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS) [J].
Chandra, HR ;
Choudhary, N ;
O'Neill, C ;
Boura, J ;
Timmis, GC ;
O'Neill, WW .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :214-218
[6]   Chlamydia pneumoniae and the risk of first ischemic stroke -: The Northern Manhattan Stroke Study [J].
Elkind, MSV ;
Lin, IF ;
Grayston, JT ;
Sacco, RL .
STROKE, 2000, 31 (07) :1521-1525
[7]   Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice [J].
Ezzahiri, R ;
Nelissen-Vrancken, HJMG ;
Kurvers, HAJM ;
Stassen, FRM ;
Vliegen, I ;
Grauls, GELM ;
van Pul, MML ;
Kitslaar, PJEHM ;
Bruggeman, CA .
CARDIOVASCULAR RESEARCH, 2002, 56 (02) :269-276
[8]   MECHANISMS LEADING TO MYOCARDIAL-INFARCTION - INSIGHTS FROM STUDIES OF VASCULAR BIOLOGY [J].
FUSTER, V .
CIRCULATION, 1994, 90 (04) :2126-2146
[9]   INCREASED EXPRESSION OF MATRIX METALLOPROTEINASES AND MATRIX-DEGRADING ACTIVITY IN VULNERABLE REGIONS OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GALIS, ZS ;
SUKHOVA, GK ;
LARK, MW ;
LIBBY, P .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2493-2503
[10]  
Gupta S, 1997, CIRCULATION, V96, P404